elliptinium has been researched along with Leukemia L 1210 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, S; el-Hamouly, W; Modi, SP; Portuese, E; Ruckdeschel, JC | 1 |
| Auclair, C; Banoun, H; Bernadou, J; Meunier, B; Paoletti, C; Voisin, E | 1 |
| Bernadou, J; Meunier, B; Meunier, G; Paoletti, C | 1 |
| Kerrigan, D; Pommier, Y; Schwartz, R; Zwelling, LA | 1 |
| Kerrigan, D; Kohn, KW; Michaels, S; Pommier, Y; Zwelling, LA | 1 |
| Capranico, G; Kohn, KW; Orr, A; Pommier, Y | 1 |
| Auclair, C; Dugue, B; Meunier, B | 1 |
| Kohn, KW; Minford, JK; Pommier, Y; Schwartz, RE; Zwelling, LA | 1 |
| Bernadou, J; Cros, S; Gillet, B; Guittet, E; Ha, T; Meunier, B; Meunier, G; Pratviel, G | 1 |
9 other study(ies) available for elliptinium and Leukemia L 1210
| Article | Year |
|---|---|
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Ellipticines; Humans; Leukemia L1210; Lung Neoplasms; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
Topics: Alkaloids; Amino Acids; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ellipticines; Intercalating Agents; Leukemia L1210; Mice; Solubility | 1984 |
omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Division; Ellipticines; Leukemia L1210; Mice; Microsomes, Liver; Oxygen Consumption; Quinones; Spectrophotometry, Ultraviolet | 1983 |
The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei.
Topics: Aminacrine; Animals; Cell Nucleus; Daunorubicin; DNA Repair; Ellipticines; Kinetics; Leukemia L1210; Mice | 1982 |
Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium.
Topics: Alkaloids; Animals; Cells, Cultured; Colony-Forming Units Assay; Cross-Linking Reagents; DNA, Neoplasm; Ellipticines; Leukemia L1210; Mice; Neoplasm Proteins; Temperature | 1982 |
Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
Topics: Amsacrine; Animals; Base Sequence; Daunorubicin; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Viral; Ellipticines; Genome, Viral; Kinetics; Leukemia L1210; Mice; Molecular Sequence Data; Restriction Mapping; Simian virus 40; Substrate Specificity; Teniposide | 1991 |
Covalent binding of elliptinium acetate (NSC 264137) to nucleic acids of L1210 cells in culture.
Topics: Alkaloids; Alkylation; Animals; Antineoplastic Agents; Cells, Cultured; DNA; Ellipticines; Kinetics; Leukemia L1210; Mice; Nucleic Acids; Oxidation-Reduction; RNA; Structure-Activity Relationship; Tritium | 1986 |
Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.
Topics: Alkaloids; Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Binding Sites; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Neoplasm; Ellipticines; Intercalating Agents; Kinetics; Leukemia L1210; Mice; Protein Binding | 1985 |
Ribose as the preferential target for the oxidized form of elliptinium acetate in ribonucleos(t)ides. Biological activities of the resulting adducts.
Topics: Alkaloids; Alkylation; Animals; Antineoplastic Agents; Cell Division; Chromatography, High Pressure Liquid; Ellipticines; Leukemia L1210; Mice; Ribonucleosides; Ribonucleotides; Ribose | 1986 |